Helen Findlow

1.6k total citations
52 papers, 994 citations indexed

About

Helen Findlow is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Helen Findlow has authored 52 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 52 papers in Microbiology and 3 papers in Infectious Diseases. Recurrent topics in Helen Findlow's work include Bacterial Infections and Vaccines (52 papers), Pneumonia and Respiratory Infections (48 papers) and Influenza Virus Research Studies (26 papers). Helen Findlow is often cited by papers focused on Bacterial Infections and Vaccines (52 papers), Pneumonia and Respiratory Infections (48 papers) and Influenza Virus Research Studies (26 papers). Helen Findlow collaborates with scholars based in United Kingdom, United States and France. Helen Findlow's co-authors include Ray Borrow, Elizabeth Miller, Jamie Findlow, Nick Andrews, Jo Southern, Anna England, Pauline Waight, Xilian Bai, Caroline Trotter and Shamez Ladhani and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Helen Findlow

52 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Findlow United Kingdom	19	860	823	104	92	85	52	994
Xilian Bai United Kingdom	17	750 0.9×	748 0.9×	84 0.8×	105 1.1×	86 1.0×	38	924
Swei‐Ju Chang United States	13	765 0.9×	648 0.8×	168 1.6×	124 1.3×	56 0.7×	17	891
Dorothee Kieninger Germany	11	680 0.8×	481 0.6×	100 1.0×	73 0.8×	86 1.0×	16	775
ChrisAnna M. Mink United States	16	857 1.0×	801 1.0×	176 1.7×	90 1.0×	99 1.2×	27	1.0k
Dominique Boutriau Belgium	21	784 0.9×	765 0.9×	168 1.6×	37 0.4×	90 1.1×	37	1.0k
Rhonwen Morris United Kingdom	16	1.2k 1.4×	940 1.1×	88 0.8×	26 0.3×	113 1.3×	24	1.3k
Olivier Van Der Meeren Belgium	15	550 0.6×	328 0.4×	217 2.1×	127 1.4×	75 0.9×	40	709
Mary Matheson United Kingdom	12	401 0.5×	434 0.5×	85 0.8×	67 0.7×	49 0.6×	18	550
David L. Klein United States	9	627 0.7×	603 0.7×	116 1.1×	50 0.5×	39 0.5×	21	792
Ray Borrow United Kingdom	14	557 0.6×	581 0.7×	44 0.4×	30 0.3×	66 0.8×	39	671

Countries citing papers authored by Helen Findlow

Since Specialization

Citations

This map shows the geographic impact of Helen Findlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Findlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Findlow more than expected).

Fields of papers citing papers by Helen Findlow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Findlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Findlow. The network helps show where Helen Findlow may publish in the future.

Co-authorship network of co-authors of Helen Findlow

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Findlow. A scholar is included among the top collaborators of Helen Findlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Findlow. Helen Findlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davis, Kimberly, Marta Valente Pinto, Nick Andrews, et al.. (2021). Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial. The Lancet Infectious Diseases. 21(5). 688–696. 5 indexed citations

Norheim, Gunnstein, Judith E. Mueller, Berthe‐Marie Njanpop‐Lafourcade, et al.. (2018). Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007. Vaccine. 36(10). 1297–1303. 1 indexed citations

Tashani, Mohamed, Mohammad Alfelali, Osamah Barasheed, et al.. (2018). Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial. Vaccine. 36(29). 4375–4382. 5 indexed citations

Findlow, Helen & Ray Borrow. (2015). Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?. Human Vaccines & Immunotherapeutics. 11(6). 1501–1506. 1 indexed citations

Findlow, Helen, Samba O. Sow, Olubukola T. Idoko, et al.. (2015). Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12–23 Months Following Meningococcal Vaccination. Clinical Infectious Diseases. 61(suppl_5). S563–S569. 5 indexed citations

Ishola, David, Nick Andrews, Pauline Waight, et al.. (2015). Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age. The Pediatric Infectious Disease Journal. 34(8). 865–874. 16 indexed citations

Price, Gregory A., Brian D. Plikaytis, George M. Carlone, et al.. (2015). Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays. Clinical Infectious Diseases. 61(suppl_5). S554–S562. 6 indexed citations

Basta, Nicole E., Ray Borrow, Uma Onwuchekwa, et al.. (2015). Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali. Clinical Infectious Diseases. 61(suppl_5). S547–S553. 1 indexed citations

Ladhani, Shamez, Nick Andrews, Jo Southern, et al.. (2015). Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator. Clinical Infectious Diseases. 61(11). 1637–1644. 129 indexed citations

10.

Townsend, Kelly, Shamez Ladhani, Helen Findlow, & Ray Borrow. (2014). Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection. Vaccine. 32(43). 5650–5656. 19 indexed citations

11.

Findlow, Jamie, Helen Findlow, Sarah Frankland, et al.. (2014). Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine. Journal of Occupational Medicine and Toxicology. 9(1). 26–26. 2 indexed citations

12.

Idoko, Olubukola T., S.N. Okolo, Brian D. Plikaytis, et al.. (2014). The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines. Vaccine. 32(33). 4220–4227. 12 indexed citations

13.

Findlow, Helen & Ray Borrow. (2013). Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT. Advances in Therapy. 30(5). 431–458. 22 indexed citations

14.

Trotter, Caroline, Seydou Yaro, Berthe‐Marie Njanpop‐Lafourcade, et al.. (2013). Seroprevalence of Bactericidal, Specific IgG Antibodies and Incidence of Meningitis Due to Group A Neisseria meningitidis by Age in Burkina Faso 2008. PLoS ONE. 8(2). e55486–e55486. 22 indexed citations

15.

Khalil, Mohamed, et al.. (2012). Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine. Clinical and Vaccine Immunology. 19(10). 1561–1566. 8 indexed citations

16.

Wing, James B., Ray Borrow, Jamie Findlow, et al.. (2012). Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity. PLoS ONE. 7(2). e31160–e31160. 2 indexed citations

17.

Findlow, Helen, Ray Borrow, Nick Andrews, et al.. (2012). Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom. The Pediatric Infectious Disease Journal. 31(6). 616–622. 25 indexed citations

18.

Wing, James B., Ray Borrow, Jamie Findlow, et al.. (2011). Kinetics of Immune Responses to Nasal Challenge With Meningococcal Polysaccharide One Year After Serogroup-C Glycoconjugate Vaccination. Clinical Infectious Diseases. 52(11). 1317–1323. 12 indexed citations

19.

Yaro, Seydou, Yves Traoré, Zékiba Tarnagda, et al.. (2007). Meningococcal carriage and immunity in western Burkina Faso, 2003. Vaccine. 25. A42–A46. 5 indexed citations

20.

Hamidou, Amina Amadou, Saacou Djibo, Ali Mahamane, et al.. (2006). Prospective survey on carriage of Neisseria meningitidis and protective immunity to meningococci in schoolchildren in Niamey (Niger): focus on serogroup W135. Microbes and Infection. 8(8). 2098–2104. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact